about
Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug SensitivityTargeting a cell state common to triple-negative breast cancersCLP1 links tRNA metabolism to progressive motor-neuron loss.Exploiting epigenetic vulnerabilities for cancer therapeutics.MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.Intron excision from precursor tRNA molecules in mammalian cells requires ATP hydrolysis and phosphorylation of tRNA-splicing endonuclease components.High-throughput genome-wide phenotypic screening via immunomagnetic cell sortingGlobal Genetic Networks and the Genotype-to-Phenotype RelationshipCRISPR screens are feasible in TP53 wild-type cellsEssential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesGenetic interaction networks in cancer cells
P50
Q28553888-B080F3C1-FBDC-42F6-B81E-95255F94F1CCQ35174128-E09E636B-994A-4707-A5C3-3A6597E9CE61Q36907351-D8C5697C-8D6E-4FF0-8F38-5518D12861DAQ38188226-474A2E5B-A1C8-45C8-85EC-BDD740C4AEB7Q42354586-F0C45C22-200B-45CC-A4E0-5B6EC17A66E2Q47113171-2BB4D3D4-C01B-4B26-8F13-A02A50C70318Q53098133-089EB78D-96F7-47F9-9C5A-2121E2AC069AQ90242091-0980CB41-2AB0-43BF-B329-78A78F636111Q92555567-04143391-2357-4B01-B295-28605BD53870Q92975807-B2CEE911-1665-4CD7-AE7F-D3ECFF5E06CBQ93003253-EC770137-FA31-478B-8F66-6914E9CC41DAQ93029325-F409DB8C-5A80-48C2-8448-BB70963B32C2
P50
description
researcher, ORCID id # 0000-0001-6982-2529
@en
wetenschapper
@nl
name
Barbara Mair
@ast
Barbara Mair
@en
Barbara Mair
@es
Barbara Mair
@nl
type
label
Barbara Mair
@ast
Barbara Mair
@en
Barbara Mair
@es
Barbara Mair
@nl
prefLabel
Barbara Mair
@ast
Barbara Mair
@en
Barbara Mair
@es
Barbara Mair
@nl
P106
P21
P31
P496
0000-0001-6982-2529